Tempus AI

Tempus AI operates one of the world's largest libraries of clinical and molecular data, combined with an AI-powered analytics platform for precision medicine. The company provides next-generation sequencing, molecular profiling, and algorithmic clinical decision support tools to physicians and pharmaceutical companies. Tempus went public in June 2024 at a valuation exceeding $6 billion, making it one of the largest AI healthcare IPOs.

$410M (IPO) + prior venture rounds

Total raised

Operates one of the world's largest libraries of clinical and molecular data, with an AI platform for genomic sequencing, molecular profiling, algorithmic treatment matching, and clinical trial optimization. Serves both clinical (physician decision support) and research (pharma R&D) use cases.